Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol Effect on Amphetamine-induced Dopamine Release
NCT03103750Phase 1Completed
- Sponsor
- Yale University
- Start
- Aug 2017
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of calcitriol in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Yale University. Primary endpoint: Non-displaceable Tracer Binding Potentials at Day 7. Started Aug 2017; status: completed.
02
Drugs
calcitriol
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03103750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103750.